Safety and Treatment Completion of 1HP Versus 3HP in People With HIV [on virally suppressed DTG]: The One-to-Three Trial

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026


Safety and Treatment Completion of 1HP Versus 3HP in People With HIV [on virally suppressed DTG]: The One-to-Three Trial

	CROI 2026 Feb 22-25 Denver